Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi bolsters its position on multiple sclerosis with a $765M BTK licensing deal
Sanofi bolsters its position on multiple sclerosis with a $765M BTK licensing deal
Sanofi bolsters its position on multiple sclerosis with a $765M BTK licensing deal
Submitted by
admin
on November 9, 2017 - 12:02pm
Source:
Endpoints
News Tags:
Sanofi
multiple sclerosis
MS
Principia Biopharma
Headline:
Sanofi bolsters its position on multiple sclerosis with a $765M BTK licensing deal
Do Not Allow Advertisers to Use My Personal information